The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owen, C. A.
Right arrow Articles by Campbell, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owen, C. A.
Right arrow Articles by Campbell, E. J.

The Journal of Immunology, Vol 155, Issue 12 5803-5810, Copyright © 1995 by American Association of Immunologists


ARTICLES

Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G

CA Owen, MA Campbell, SS Boukedes and EJ Campbell
Department of Medicine, University of Utah Health Sciences Center, Salt Lake City 84132, USA.

Catalytically active cathepsin G that is bound to the cell surface of human neutrophils may play a variety of roles in normal neutrophil biology and in pathobiology associated with inflammation. In this study, we describe expression of neutrophil cell surface-bound cathepsin G in response to TNF-alpha and platelet-activating factor (PAF) under conditions in which minimal free release of cathepsin G is detected. TNF-alpha and PAF alone induced modest (two- to threefold) increases in cell surface-bound cathepsin G, but exhibited a marked dose- and time-dependent priming effect for subsequent chemoattractant- induced responses (up to 15- to 25-fold increases in cell surface expression). When optimally primed (TNF-alpha, 100 U/ml, or PAF, 10(-9) M), neutrophils expressed five- to sixfold more cell surface-bound cathepsin G, in comparison with cells exposed to FMLP alone. Priming responses were more rapid with PAF (15 s to 5 min) than with TNF-alpha (1 to 60 min). Optimally primed and FMLP-stimulated neutrophils express approximately 160 ng of catalytically active cathepsin G per 10(6) cells, which represents approximately 11% of the cellular content of unstimulated cells. Cathepsin G binds to the cell surface by a charge- dependent mechanism since: 1) incubation of cells with highly positively charged molecules abrogated agonist-induced up-regulation of the cell surface expression of cathepsin G and 2) cathepsin G was eluted from the cell surface by high concentrations of NaCl. These data indicate that interactions between biologically relevant pro- inflammatory cytokines and chemoattractants serve to markedly up- regulate cell surface-bound cathepsin G. The focused catalytic activity of cell surface-bound cathepsin G may alter endothelial and epithelial barriers, promote thrombogenesis, injure extracellular matrix, and/or facilitate directed migration of neutrophils during inflammation.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. J. Campbell and C. A. Owen
The Sulfate Groups of Chondroitin Sulfate- and Heparan Sulfate-containing Proteoglycans in Neutrophil Plasma Membranes Are Novel Binding Sites for Human Leukocyte Elastase and Cathepsin G
J. Biol. Chem., May 11, 2007; 282(19): 14645 - 14654.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. K. Lim, W. Lu, O. Hartley, and A. L. DeVico
N-terminal proteolytic processing by cathepsin G converts RANTES/CCL5 and related analogs into a truncated 4-68 variant
J. Leukoc. Biol., December 1, 2006; 80(6): 1395 - 1404.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. Schiemann, T. A. Grimm, J. Hoch, R. Gross, B. Lindner, F. Petersen, S. Bulfone-Paus, and E. Brandt
Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G
Blood, March 15, 2006; 107(6): 2234 - 2242.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Wittamer, B. Bondue, A. Guillabert, G. Vassart, M. Parmentier, and D. Communi
Neutrophil-Mediated Maturation of Chemerin: A Link between Innate and Adaptive Immunity
J. Immunol., July 1, 2005; 175(1): 487 - 493.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Owen, Z. Hu, C. Lopez-Otin, and S. D. Shapiro
Membrane-Bound Matrix Metalloproteinase-8 on Activated Polymorphonuclear Cells Is a Potent, Tissue Inhibitor of Metalloproteinase-Resistant Collagenase and Serpinase
J. Immunol., June 15, 2004; 172(12): 7791 - 7803.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
F Rubio, J Cooley, F J Accurso, and E Remold-O'Donnell
Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease
Thorax, April 1, 2004; 59(4): 318 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
L. Ottonello, A. L. Epstein, M. Mancini, P. Dapino, and F. Dallegri
Monoclonal LYM-1 antibody-dependent cytolysis by human neutrophils exposed to GM-CSF: auto-regulation of target cell attack by cathepsin G
J. Leukoc. Biol., January 1, 2004; 75(1): 99 - 105.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
C. A. Owen, Z. Hu, B. Barrick, and S. D. Shapiro
Inducible Expression of Tissue Inhibitor of Metalloproteinases-Resistant Matrix Metalloproteinase-9 on the Cell Surface of Neutrophils
Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): 283 - 294.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Hermant, S. Bibert, E. Concord, B. Dublet, M. Weidenhaupt, T. Vernet, and D. Gulino-Debrac
Identification of Proteases Involved in the Proteolysis of Vascular Endothelium Cadherin during Neutrophil Transmigration
J. Biol. Chem., April 11, 2003; 278(16): 14002 - 14012.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. J. Campbell, M. A. Campbell, and C. A. Owen
Bioactive Proteinase 3 on the Cell Surface of Human Neutrophils: Quantification, Catalytic Activity, and Susceptibility to Inhibition
J. Immunol., September 15, 2000; 165(6): 3366 - 3374.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Le-Barillec, D. Pidard, V. Balloy, and M. Chignard
Human neutrophil cathepsin G down-regulates LPS-mediated monocyte activation through CD14 proteolysis
J. Leukoc. Biol., August 1, 2000; 68(2): 209 - 215.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
G. R. Sambrano, W. Huang, T. Faruqi, S. Mahrus, C. Craik, and S. R. Coughlin
Cathepsin G Activates Protease-activated Receptor-4 in Human Platelets
J. Biol. Chem., March 15, 2000; 275(10): 6819 - 6823.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Owaki, A. Meneshian, K. Maemura, S. Takao, D. Wang, K. C. Fuh, G. B. Bulkley, and A. S. Klein
Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release
Am J Physiol Heart Circ Physiol, January 1, 2000; 278(1): H269 - H276.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. A. Owen and E. J. Campbell
Angiotensin II Generation at the Cell Surface of Activated Neutrophils: Novel Cathepsin G-Mediated Catalytic Activity That Is Resistant to Inhibition
J. Immunol., February 1, 1998; 160(3): 1436 - 1443.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
G HERRERO-BEAUMONT and J EGIDO
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage
Ann Rheum Dis, April 1, 1997; 56(4): 211 - 213.
[Full Text]


Home page
BloodHome page
P. Renesto, M. Si-Tahar, M. Moniatte, V. Balloy, A. Van Dorsselaer, D. Pidard, and M. Chignard
Specific Inhibition of Thrombin-Induced Cell Activation by the Neutrophil Proteinases Elastase, Cathepsin G, and Proteinase 3: Evidence for Distinct Cleavage Sites Within the Aminoterminal Domain of the Thrombin Receptor
Blood, March 15, 1997; 89(6): 1944 - 1953.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.